Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Details

Title
Publisher Correction: A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131
Author
Maes Mailis 1 ; Dyson, Zoe A 2 ; Smith, Sarah E 3 ; Goulding, David A 4 ; Ludden, Catherine 5 ; Baker, Stephen 1 ; Kellam, Paul 6 ; Reece, Stephen T 3 ; Dougan, Gordon 1 ; Bartholdson Scott Josefin 1 

 University of Cambridge, Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934) 
 University of Cambridge, Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, Cambridge, UK (GRID:grid.5335.0) (ISNI:0000000121885934); Monash University, Department of Infectious Diseases, Central Clinical School, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); London School of Hygiene and Tropical Medicine, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X) 
 Kymab Ltd, Cambridge, UK (GRID:grid.479336.c) (ISNI:0000 0004 4670 699X) 
 Wellcome Sanger Institute, Hinxton, UK (GRID:grid.10306.34) (ISNI:0000 0004 0606 5382) 
 London School of Hygiene and Tropical Medicine, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X) 
 Kymab Ltd, Cambridge, UK (GRID:grid.479336.c) (ISNI:0000 0004 4670 699X); Imperial College London, Department of Infectious Disease, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2505573717
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.